Kling doses first subject in Phase Ib solid tumour antibody trial
Netherlands
ISA concludes subject enrolment in HPV16 positive OPC therapy trial
The trial will assess ISA101b’s safety and efficacy in HPV16 positive OPC patients.
Akston doses first subjects in Phase II Covid-19 booster trial
Akston to launch Phase II trial of Covid-19 booster vaccine in Netherlands
NewAmsterdam Pharma reports positive data in Phase II dyslipidemia trial
Triall enters partnership to anchor Covid-19 data to blockchain
Akston initiates subject dosing in Phase II Covid-19 vaccine trial
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox
